No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Corundum Systems Biology Opens U.S. Office to Expand Presence in North America
Corundum Systems Biology Supports Expansion of World's Deepest Multiomic Dataset Into Japan
Otake: Half Year Report - Term 73 (2024/06/01 - 2025/05/31)
Otake: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending May 2025 [Japanese GAAP] (consolidated)
Otake: Notice regarding publication of consolidated earnings forecasts due to the transition to consolidated financial results
Otake 1H Net Y415.00M